The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Collaborations and Projects

Pre-GMP Facility at Lund University

Photo of vials.

The Pre GMP Facility at Lund University, established by the Lund Stem Cell Center, serves as a platform for pioneering groundbreaking projects in regenerative medicine and advanced therapy medicinal products (ATMPs). Supported by the Lund University ATMP Centre (LU-ATMP), it promotes research and development by combining expertise from academia, industry, and healthcare to translate scientific discoveries into clinical applications for improved patient care.

Learn more about our ongoing collaborations and projects:

ATMP Path2Patient


The project aims to provide academia, healthcare, and the business-promoting innovation ecosystem in Skåne-Blekinge with better conditions to support the commercialization of ATMPs. This will be achieved by creating new testing and demonstration environments and making these and other important resources, such as the right skills, networks, and capital, available to researchers and startups working in the ATMP field. 

The long-term goal is to sustainably increase the number of company establishments, increase the translation of cutting-edge research, and accelerate the speed at which potentially curative ATMP treatments reach more patients with significant medical needs. To achieve the necessary systems thinking, partners will work together to increase their knowledge of the challenges and opportunities in the ATMP field. Within the framework of the project, relevant networks will also be built and new processes, methods, and tools will be developed and implemented in new testing and innovation environments, such as the Lund University's Pre-GMP Facility.

ATMP Path2Patient is led by Lund University's innovation office, LU Innovation, and is being carried out in collaboration with SmiLe Venture Hub, Medicon Village Innovation, the Pre-GMP facility at Lund University (LU-ATMP), and Region Skåne's ATMP center.

Read the press release about the project launch at lu.se (in Swedish).

EU financing logo

 


 

 

ATMP Pipeline Reports


The recent ATMP Pipeline Reports produced by the Pre-GMP Facility summarize ongoing ATMP projects and company activities in Lund and across southern Sweden, highlighting key developments and milestones.

Lund Stem Cell Center ATMP Pipeline Report 2024

Lund Stem Cell Center ATMP Pipeline Report 2023

Contact Us

For inquiries, training, or access requests, contact: pre-gmp [at] med [dot] lu [dot] se (pre-gmp[at]med[dot]lu[dot]se)


Visit Us:

Pre-GMP Facility
Lund University,
BMC C9, Klinkgatan 28,
221 84 Lund, Sweden